Bumcrot David 4
4 · Camp4 Therapeutics Corp · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Bumcrot David
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-01+45,000→ 45,000 totalExercise: $3.86Exp: 2035-03-31→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.